ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.31
0.26%
US Tech 100
18,564.00
0.25%
S&P 500
5,360.79
0.26%
US Dollar vs CAD
1.37614
0.00%
Bitcoin
67,843.14
-2.40%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Lumos Pharma Inc (LUMO)

  7. Lumos Pharma Inc (LUMO) News

LUMO

Lumos Pharma (LUMO)

Lumos Pharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:LUMO
DateTimeSourceHeadlineSymbolCompany
06/07/20243:08PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LUMOLumos Pharma Inc
06/07/20243:07PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LUMOLumos Pharma Inc
06/07/20243:07PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LUMOLumos Pharma Inc
06/07/20243:07PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LUMOLumos Pharma Inc
06/07/20243:07PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LUMOLumos Pharma Inc
06/07/20243:06PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LUMOLumos Pharma Inc
06/05/20243:09PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LUMOLumos Pharma Inc
06/04/20244:02PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LUMOLumos Pharma Inc
06/04/20248:00AMGlobeNewswire Inc.Lumos Pharma Announces New Analyses of Phase 2 OraGrowtH212 Trial Presented at ENDO 2024NASDAQ:LUMOLumos Pharma Inc
05/20/20243:05PMGlobeNewswire Inc.Lumos Pharma Announces Abstracts Accepted for Presentation at ENDO 2024NASDAQ:LUMOLumos Pharma Inc
05/15/20248:57AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LUMOLumos Pharma Inc
05/14/20243:15PMGlobeNewswire Inc.Lumos Pharma Announces Positive End-of-Phase 2 Meeting with FDA and Reports First Quarter 2024 Financial ResultsNASDAQ:LUMOLumos Pharma Inc
05/09/20241:51PMGlobeNewswire Inc.Lumos Pharma to Report First Quarter 2024 Financial Results and Provide Clinical Update on May 15, 2024NASDAQ:LUMOLumos Pharma Inc
04/18/20243:05PMGlobeNewswire Inc.Lumos Pharma Announces Abstracts Accepted for Presentation at Upcoming Medical MeetingsNASDAQ:LUMOLumos Pharma Inc
03/20/20247:00AMGlobeNewswire Inc.Lumos Pharma Announces that the USPTO Has Granted Patent Protection for Novel Formulation of LUM-201, Extending Exclusivity to 2042NASDAQ:LUMOLumos Pharma Inc
03/07/20243:48PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:LUMOLumos Pharma Inc
03/07/20243:44PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LUMOLumos Pharma Inc
03/07/20243:01PMGlobeNewswire Inc.Lumos Pharma Reports Full Year 2023 Financial Results and Provides Clinical Development UpdateNASDAQ:LUMOLumos Pharma Inc
02/26/20248:00AMGlobeNewswire Inc.Lumos Pharma to Report Full Year 2023 Financial Results and Host Conference Call on March 7, 2024NASDAQ:LUMOLumos Pharma Inc
02/07/20244:22PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LUMOLumos Pharma Inc
02/06/20243:02PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LUMOLumos Pharma Inc
02/05/20244:55PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LUMOLumos Pharma Inc
02/05/20244:54PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LUMOLumos Pharma Inc
02/05/20244:53PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LUMOLumos Pharma Inc
02/05/20244:52PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LUMOLumos Pharma Inc
02/05/20244:51PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LUMOLumos Pharma Inc
02/05/20243:05PMGlobeNewswire Inc.Lumos Pharma to Participate in Oppenheimer’s 34th Annual Healthcare Life Sciences ConferenceNASDAQ:LUMOLumos Pharma Inc
01/10/20246:03PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:LUMOLumos Pharma Inc
01/04/20243:34PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LUMOLumos Pharma Inc
01/04/20243:05PMGlobeNewswire Inc.Lumos Pharma Promotes Pisit “Duke” Pitukcheewanont, MD to Chief Medical OfficerNASDAQ:LUMOLumos Pharma Inc
 Showing the most relevant articles for your search:NASDAQ:LUMO

Your Recent History

LSE
BY05
Citi Fun 24
ASX
PRSOA
Prospech
LSE
SPMU
Spiritus Mundi
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved